|
DK166763B1
(da)
|
1983-03-16 |
1993-07-12 |
Immuno Ag |
Immunoglobulin-g-holdig fraktion
|
|
AT376367B
(de)
|
1983-03-16 |
1984-11-12 |
Immuno Ag |
Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten
|
|
DE3473407D1
(en)
|
1983-05-02 |
1988-09-22 |
Immuno Ag |
Method of inactivating pathogens
|
|
AT389815B
(de)
|
1984-03-09 |
1990-02-12 |
Immuno Ag |
Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
|
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
|
AT390560B
(de)
|
1986-05-30 |
1990-05-25 |
Immuno Ag |
Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
|
|
US4987071A
(en)
|
1986-12-03 |
1991-01-22 |
University Patents, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
JP2871709B2
(ja)
|
1988-11-21 |
1999-03-17 |
住友製薬株式会社 |
免疫グロブリンｇ結合活性を有する新規な蛋白質プロテインｈ、該蛋白質をコードする遺伝子及び該蛋白質の製造法
|
|
US5177194A
(en)
|
1990-02-01 |
1993-01-05 |
Baxter International, Inc. |
Process for purifying immune serum globulins
|
|
IE66205B1
(en)
|
1990-06-14 |
1995-12-13 |
Paul A Bartlett |
Polypeptide analogs
|
|
US5650489A
(en)
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
|
ATE300615T1
(de)
|
1990-08-29 |
2005-08-15 |
Genpharm Int |
Transgene mäuse fähig zur produktion heterologer antikörper
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
AT402891B
(de)
|
1991-06-20 |
1997-09-25 |
Immuno Ag |
Verfahren zur herstellung eines inaktivierten blutproduktes
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
US5885527A
(en)
|
1992-05-21 |
1999-03-23 |
Biosite Diagnostics, Inc. |
Diagnostic devices and apparatus for the controlled movement of reagents without membrances
|
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
|
WO1994013329A1
(de)
|
1992-12-16 |
1994-06-23 |
Immuno Aktiengesellschaft |
Verfahren zur herstellung eines virussicheren biologischen präparates
|
|
HRP940645A2
(en)
|
1993-10-06 |
1996-12-31 |
Immuno Ag |
Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
|
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
|
US5593853A
(en)
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
|
US6447796B1
(en)
|
1994-05-16 |
2002-09-10 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
|
US5525735A
(en)
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
|
US5549974A
(en)
|
1994-06-23 |
1996-08-27 |
Affymax Technologies Nv |
Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
|
|
US5569588A
(en)
|
1995-08-09 |
1996-10-29 |
The Regents Of The University Of California |
Methods for drug screening
|
|
US20020114802A1
(en)
|
1998-02-10 |
2002-08-22 |
Tjellstrom Bo Arthur Einar |
Oral immunoglobulin treatment for inflammatory bowel disease
|
|
DE60040274D1
(de)
|
1999-03-10 |
2008-10-30 |
Phogen Ltd |
Verabreichung von nukleinsäuren und proteinen an zellen
|
|
AU2001273661A1
(en)
|
2000-06-30 |
2002-01-14 |
Duke University |
Methods of screening for alzheimer's disease
|
|
US20020098182A1
(en)
|
2000-09-28 |
2002-07-25 |
Richard Weisbart |
Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G
|
|
US20020130430A1
(en)
|
2000-12-29 |
2002-09-19 |
Castor Trevor Percival |
Methods for making polymer microspheres/nanospheres and encapsulating therapeutic proteins and other products
|
|
WO2002059604A2
(en)
|
2001-01-26 |
2002-08-01 |
Oxford Glycosciences (Uk) Ltd |
Diagnosis and treatment of multiple sclerosis
|
|
US6905827B2
(en)
*
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
|
CA2462682A1
(en)
|
2001-10-04 |
2003-04-10 |
Protein Therapeutics, Inc. |
The use of gammaglobulin for the treatment of immune-mediated diseases
|
|
US7060498B1
(en)
|
2001-11-28 |
2006-06-13 |
Genta Salus Llc |
Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
|
|
US7141540B2
(en)
|
2001-11-30 |
2006-11-28 |
Genta Salus Llc |
Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof
|
|
US7442512B2
(en)
*
|
2001-11-30 |
2008-10-28 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US20050222064A1
(en)
|
2002-02-20 |
2005-10-06 |
Sirna Therapeutics, Inc. |
Polycationic compositions for cellular delivery of polynucleotides
|
|
WO2003081201A2
(en)
*
|
2002-03-21 |
2003-10-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
|
|
US20040014109A1
(en)
*
|
2002-05-23 |
2004-01-22 |
Pericak-Vance Margaret A. |
Methods and genes associated with screening assays for age at onset and common neurodegenerative diseases
|
|
WO2004005534A2
(en)
|
2002-07-08 |
2004-01-15 |
Duke University |
Screening for alzheimer's disease
|
|
ES2343318T3
(es)
|
2002-11-26 |
2010-07-28 |
University Of Massachusetts |
Administracion de arnsis.
|
|
US20050064516A1
(en)
|
2003-09-18 |
2005-03-24 |
Kantor Aaron B. |
Biological markers for diagnosing multiple sclerosis
|
|
CA2549720C
(en)
|
2003-12-19 |
2013-10-15 |
Chiron Corporation |
Cell transfecting formulations of small interfering rna, related compositions and methods of making and use
|
|
WO2005067391A2
(en)
|
2004-01-19 |
2005-07-28 |
Technion Research & Development Foundation Ltd. |
Diagnostic test for parkinson's disease
|
|
US20060014289A1
(en)
|
2004-04-20 |
2006-01-19 |
Nastech Pharmaceutical Company Inc. |
Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells
|
|
US7514530B2
(en)
|
2004-04-26 |
2009-04-07 |
Centre National De La Recherche Scientifique |
Peptide carrier for delivering siRNA into mammalian cells
|
|
JP2008526245A
(ja)
|
2005-01-19 |
2008-07-24 |
バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト |
多発性硬化症の患者における疾患および疾患活性の両方と相関するマーカーとしてのｃｘ３ｃｒ１
|
|
CA2601157A1
(en)
*
|
2005-03-16 |
2006-09-28 |
Osi Pharmaceuticals, Inc. |
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
|
|
US20080045582A1
(en)
*
|
2006-05-15 |
2008-02-21 |
Issam Zineh |
ENA-78 Gene Polymorphisms and Protein Concentrations as Diagnostic and Prognostic Tools
|
|
US20100112568A1
(en)
*
|
2006-12-29 |
2010-05-06 |
Tel Hashomer Medical Research Infrastructure And S |
Methods and kits for diagnosis of multiple sclerosis in probable multiple sclerosis subjects
|
|
JO3421B1
(ar)
|
2011-06-20 |
2019-10-20 |
H Lundbeck As |
طريقة لإعطاء 1-((1ار.3س)-6-كلورو-3-فينيل-اندان-1-ايل)-1.2.2-ترايميثيل- بيبيرازين واملاجها لمعالجة انفصام الشخصية
|